Drug intelligence / Profile preview

PROfertil

Development stage: Unknown
Lead developer: Lenus Pharma
Modality: Small Molecules
Administration: Oral

Overview

PROfertil is a standardized multinutrient supplementation designed to support female fertility, particularly in women suffering from Polycystic Ovary Syndrome (PCOS) and infertility. It is manufactured by Lenus Pharma and contains a blend of micronutrients including folic acid, selenium, vitamin E, catechins, glycyrrhizin, coenzyme Q10, and omega-3 fatty acids. The supplement is believed to exert its effects through antioxidative and anti-inflammatory properties.

Brand names: PROfertil female
Other names: PROFERTIL female

Beyond the preview

Go deeper on PROfertil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PROfertil.

Explore the full profile